Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Ten Approvals To Look Out For In Q4

Oct 10 2017

• By Alex Shimmings

Pipes — Plenty of Approvals Coming through the pipeline • Source: Shutterstock

Related Content

Pivotal ALCANZA Trial Secures Adcetris' Position in Cutaneous Lymphoma

Dec 07 2016

Indivior Leaps On Phase III Data For Depot Opioid Addiction Treatment

Aug 19 2016

Aeterna Zentaris tanks on FDA Macrilen rejection

Nov 07 2014

Kite On Course For FDA Filing On Positive CAR-T Durability Data

Mar 01 2017

New Anti-CMV Therapies Post-Transplant: Merck & Co Leads The Pack

Mar 02 2017

Indivior To Appeal US Suboxone Setback, Flags Follow-On Drug RBP-6000

Sep 02 2017

Phase III Data Back Keryx's Plan To Expand Auryxia Market

Mar 30 2016

AstraZeneca Hopes To Differentiate Benralizumab On Efficacy, Dosing Convenience

May 18 2016

Related Companies

Keryx Biopharmaceuticals Inc.

AstraZeneca PLC

GSK plc

Teva Pharmaceutical Industries Ltd.

Seagen Inc.

Merck & Co., Inc.

AiCuris Anti-infective Cures GmbH

Astellas Pharma, Inc.

Fresh Tracks Therapeutics, Inc.

Takeda Pharmaceutical Co. Ltd.

Chimerix, Inc.

Kite Pharma, Inc.

Novartis AG

Gilead Sciences, Inc.

Dynavax Technologies Corporation

Ultragenyx Pharmaceutical Inc.

COSCIENS Biopharma

Indivior plc

Additional Topics

Approvals BioPharmaceutical

More from New Products

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window